Combining a WT1 cancer vaccine (galinpepimut-S) with checkpoint inhibition (nivolumab) in patients with WT1-expressing diffuse pleural mesothelioma (DPM): A phase I study Meeting Abstract


Authors: Agrawal, P.; Offin, M.; Ginsberg, M. S.; Adusumilli, P. S.; Rusch, V. W.; Sauter, J. L.; Ho, T.; Wong, P.; Zauderer, M. G.
Abstract Title: Combining a WT1 cancer vaccine (galinpepimut-S) with checkpoint inhibition (nivolumab) in patients with WT1-expressing diffuse pleural mesothelioma (DPM): A phase I study
Meeting Title: 2024 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 42
Issue: 16 Suppl.
Meeting Dates: 2024 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2024-06-01
Language: English
ACCESSION: WOS:001275557401872
PROVIDER: wos
DOI: 10.1200/JCO.2024.42.16_suppl.8083
Notes: Meeting Abstract: 8083 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Valerie W Rusch
    865 Rusch
  2. Michelle S Ginsberg
    235 Ginsberg
  3. Phillip Wong
    80 Wong
  4. Marjorie G Zauderer
    188 Zauderer
  5. Teresa Rasalan
    33 Rasalan
  6. Michael David Offin
    170 Offin
  7. Jennifer Lynn Sauter
    124 Sauter